Correlation Between Sanyo Special and Summit Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sanyo Special and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sanyo Special and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sanyo Special Steel and Summit Therapeutics PLC, you can compare the effects of market volatilities on Sanyo Special and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sanyo Special with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sanyo Special and Summit Therapeutics.

Diversification Opportunities for Sanyo Special and Summit Therapeutics

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sanyo and Summit is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Sanyo Special Steel and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and Sanyo Special is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sanyo Special Steel are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of Sanyo Special i.e., Sanyo Special and Summit Therapeutics go up and down completely randomly.

Pair Corralation between Sanyo Special and Summit Therapeutics

Assuming the 90 days horizon Sanyo Special is expected to generate 164.16 times less return on investment than Summit Therapeutics. But when comparing it to its historical volatility, Sanyo Special Steel is 120.76 times less risky than Summit Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Summit Therapeutics PLC is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  814.00  in Summit Therapeutics PLC on September 27, 2024 and sell it today you would earn a total of  1,086  from holding Summit Therapeutics PLC or generate 133.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sanyo Special Steel  vs.  Summit Therapeutics PLC

 Performance 
       Timeline  
Sanyo Special Steel 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sanyo Special Steel are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable essential indicators, Sanyo Special is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
Summit Therapeutics PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, Summit Therapeutics is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Sanyo Special and Summit Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sanyo Special and Summit Therapeutics

The main advantage of trading using opposite Sanyo Special and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sanyo Special position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.
The idea behind Sanyo Special Steel and Summit Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance